Peptides are the newly emerging science of cell signaling amino acid sequences, with far-reaching regulatory and rejuvenation actions on neuro-endocrine-immune functionality. The specifically targeted use of peptides in the environment has the potential to rewrite bodily chemistry relationships, and ultimately generate a restorative trend towards anabolism and homeostasis. Peptides can also be utilized and applied in the treatment of injuries, with capabilities that help prevent aging, illness, and enhance peak performance. This workshop is designed to introduce healthcare providers to the core principals of specific peptides, all of which can be immediately implemented into treatment protocols. During the sessions, participants will learn the applications of Sermorelin, CJC-1295, GhRP-2, GHRP-6, Imaporelin, and BPC-157. Specific clinical case studies will be shared and discussed, demonstrating the transformations that can occur through the advanced methodologies and protocols of peptide therapy.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Washington School of Medicine and A4M. The University of Washington School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.